Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/31f31298-a544-49e1-8ab7-d3caae9549ed/
TAK
Takeda Pharmaceutical Co Ltd ADRSnapshot 2026-07-19 · 0.6w · Fresh
Strategy Eligibility
10 of 23 passing
★
OS Composite
OS 0.950
↗
Trending Value
#38
◆
Quality × Value
QV 0.824
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
P/E 0.3
◇
VC2 Cheapest
VC2 1
📐
EBITDA/EV
31.4%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
94.2%
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
Yes
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
Vol 21%
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 1.00
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
97.0%ile
P/E
0.3×
P/S
0.0×
P/B
0.0×
E/P
0.1427
FCF Yield
0.317
EBITDA/EV
0.314
SH Yield
0.942
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
1.00000000
/100 — 1=cheapest
VC2 (Trending Value)
1.00000000
/100
VC3 (Buyback)
1.00000000
/100
P/E of 0.3x places this firmly in deep value territory. FCF yield of 31.7% is strong — the business generates significant free cash relative to price. VC2 score of 1.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
70.0%ile
ROE
0.025
ROA
0.012
Net Margin
0.042
Op Margin
0.137
GPA
0.171
D/E
0.99
Current
1.27
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.007
Earn Growth
0.791
Stability
2.125
lower=better
Accruals
-0.051
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
67.0%ile
6M Return
6.1%
12M Return
21.5%
12-1 Mom
10.7%
Risk-Adj
0.50
Vol 252d
21.3%
Vol 60d
47.1%
↑ Expanding
Max DD 12M
-16.8%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (47%) is expanding vs long-term (21%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.95
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
99.4%
Sector Quality %ile
79.4%
P/E z-score
-0.50
P/B z-score
-0.33
Sector Avg OS
64.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (97th) and quality (70th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Strong Capital Return
Shareholder yield 94.2% backed by 31.7% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (47%) significantly exceeds 252-day (21%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
99.3% avg (7 factors)
Quality
D
39.8% avg (8 factors)
Momentum
C
46.9% avg (4 factors)
Risk
A
81.1% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.950 | —7 | — | |
| Value %ile | 0.970 | —7 | — | |
| Quality %ile | 0.700 | —7 | — | |
| Momentum %ile | 0.670 | —0 | — | |
| F-Score | 6.000 | —0 | — | |
| Confidence | 0.910 | —7 | — | |
| Volatility | 0.213 | —0 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
0.28
Earnings Yield (E/P)
0.1427
Price / Sales
0.01
Price / Book
0.01
Price / Cash Flow
0.06
FCF Yield
31.7%
EBITDA / EV
31.4%
Sales Yield (1/P·S)
1.0426
Shareholder Yield
Div + net buyback / mktcap
94.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
2.5%
Return on Assets
1.2%
Net Margin
4.2%
Operating Margin
13.7%
Gross Profit / Assets
Novy-Marx GPA
17.1%
Debt / Equity
0.99
Current Ratio
1.27
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.051
MomentumPrice trend strength over different horizons
6M Return
6.1%
12M Return
21.5%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
10.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.50
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-0.7%
Earnings Growth (YoY)
79.1%
Earnings Stability (CV)
Lower = more stable
2.125
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Buyback Yield
94.2%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
1
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
1
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
1
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
38
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
Yes
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity